InsiderTrades

Form 4 for APVO Aptevo Therapeutics Inc.

Accepted 2024-08-09 00:00:00 ET · period of report 2024-08-08 · accession 0000950170-24-094816 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-08-09 2024-08-08 APVO Lamothe Jeffrey G. EVP, COO M - OptEx — +314 894 +54% —
DM 2024-08-09 2024-08-08 APVO Lamothe Jeffrey G. EVP, COO M - OptEx $0.00 -314 41 -88% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-08-08 M A 272 — 1,166 D — — (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
2 Common Common Stock 2024-08-08 M A 42 — 894 D — — (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
3 Derivative Restricted Stock Unit 2024-08-08 M D 272 $0.00 0 D — · — to — 272 Common Stock (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F3) On August 9, 2022, the reporting person was granted 23,958 (544 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023.
4 Derivative Restricted Stock Unit 2024-08-08 M D 42 $0.00 41 D — · — to — 42 Common Stock (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F2) On August 9, 2022, the reporting person was granted 5,500 (125 post-split) RSUs, vesting in three approximately equal annual installments beginning on August 8, 2023.